STTK · Shattuck Labs Inc. Common Stock
View on chartInsiders & Stakes
| Redmile Group, LLC 10% Owner | ▼ Sell | Other | 5,539,724 Shares held | 12/4/2024 | View profile |
| ORBIMED ADVISORS LLC Director | ▲ Buy | Open Market | 1,051,021 Shares held | 8/25/2025 | View profile |
| Ashiya Mona Director | ▲ Buy | Open Market | 1,051,021 Shares held | 8/25/2025 | View profile |
| Clay B. Siegall President and CEO | ▲ Buy | Open Market | 318,608 Shares held | 6/9/2026 | View profile |
| Neill Andrew R Chief Financial Officer | ▲ Buy | Grant | 292,251 Shares held | 5/12/2026 | View profile |
| Tyler Brous Director | ▲ Buy | Open Market | 238,088 Shares held | 6/28/2024 | View profile |
| Pandite Arundathy N. Chief Medical Officer | ▼ Sell | Open Market | 136,219 Shares held | 6/30/2026 | View profile |
| Schreiber Taylor Chief Executive Officer | ▲ Buy | Grant | 122,222 Shares held | 5/12/2026 | View profile |
| Thomson Erin Ator General Counsel | ▲ Buy | Grant | 103,209 Shares held | 1/25/2023 | View profile |
| Shukla Abhinav A. Chief Technical Officer | ▲ Buy | Option Exercise | 98,533 Shares held | 7/6/2026 | View profile |
| Stout Stephen See Remarks | ▲ Buy | Grant | 93,366 Shares held | 5/15/2026 | View profile |
| DeYoung Casi Chief Business Officer | ▼ Sell | Tax Withholding | 73,480 Shares held | 1/25/2026 | View profile |
| George Golumbeski Director | ▲ Buy | Open Market | 54,613 Shares held | 4/26/2022 | View profile |
Transaction History
| Shukla Abhinav A. | ▲ Buy | Option Exercise | 12,153 | $43K | 7/6/2026 |
| Shukla Abhinav A. | ▲ Buy | Option Exercise | 410 | $1K | 7/2/2026 |
| Shukla Abhinav A. | ▼ Sell | Open Market | 410 | $3K | 7/2/2026 |
| Shukla Abhinav A. | ▲ Buy | Option Exercise | 100 | $357 | 7/1/2026 |
| Shukla Abhinav A. | ▼ Sell | Open Market | 100 | $707 | 7/1/2026 |
| Shukla Abhinav A. | ▲ Buy | Option Exercise | 23,365 | $83K | 6/30/2026 |
| Shukla Abhinav A. | ▼ Sell | Open Market | 23,365 | $165K | 6/30/2026 |
| Pandite Arundathy N. | ▼ Sell | Open Market | 30,000 | $210K | 6/30/2026 |
| Clay B. Siegall | ▲ Buy | Open Market | 62,500 | $250K | 6/9/2026 |
| Clay B. Siegall | ▲ Buy | Grant | 128,054 | $139K | 5/22/2026 |
| Shukla Abhinav A. | ▲ Buy | Grant | 5,122 | $6K | 5/21/2026 |
| Stout Stephen | ▲ Buy | Grant | 12,805 | $14K | 5/15/2026 |
| Neill Andrew R | ▲ Buy | Grant | 64,027 | $69K | 5/12/2026 |
| Shukla Abhinav A. | ▲ Buy | Option Exercise | 2,032 | $7K | 5/12/2026 |
| Shukla Abhinav A. | ▼ Sell | Open Market | 2,032 | $14K | 5/12/2026 |
| Pandite Arundathy N. | ▼ Sell | Open Market | 30,000 | $198K | 5/12/2026 |
| Schreiber Taylor | ▲ Buy | Grant | 25,610 | $28K | 5/12/2026 |
| Stout Stephen | ▼ Sell | Tax Withholding | 968 | $7K | 5/10/2026 |
| Pandite Arundathy N. | ▼ Sell | Tax Withholding | 3,195 | $13K | 1/25/2026 |
| Stout Stephen | ▼ Sell | Tax Withholding | 593 | $2K | 1/25/2026 |
| DeYoung Casi | ▼ Sell | Tax Withholding | 2,286 | $9K | 1/25/2026 |
| Neill Andrew R | ▼ Sell | Tax Withholding | 2,589 | $11K | 1/25/2026 |
| Stout Stephen | ▼ Sell | Tax Withholding | 4,153 | $20K | 1/10/2026 |
| DeYoung Casi | ▼ Sell | Tax Withholding | 5,699 | $27K | 1/10/2026 |
| Pandite Arundathy N. | ▼ Sell | Tax Withholding | 6,851 | $33K | 1/10/2026 |
| Neill Andrew R | ▼ Sell | Tax Withholding | 6,660 | $32K | 1/10/2026 |
| ORBIMED ADVISORS LLC | ▲ Buy | Open Market | 5,255,106 | $4.6M | 8/25/2025 |
| ORBIMED ADVISORS LLC | ▲ Buy | Open Market | 1,051,021 | $912K | 8/25/2025 |
| Ashiya Mona | ▲ Buy | Open Market | 5,255,106 | $4.6M | 8/25/2025 |
| Ashiya Mona | ▲ Buy | Open Market | 1,051,021 | $912K | 8/25/2025 |
| Stout Stephen | ▲ Buy | Grant | 12,805 | $11K | 8/25/2025 |
| Neill Andrew R | ▲ Buy | Grant | 64,027 | $56K | 8/25/2025 |
| Clay B. Siegall | ▲ Buy | Grant | 128,054 | $111K | 8/25/2025 |
| Schreiber Taylor | ▲ Buy | Grant | 25,610 | $22K | 8/25/2025 |
| Shukla Abhinav A. | ▲ Buy | Grant | 5,122 | $4K | 8/25/2025 |
| Shukla Abhinav A. | ▼ Sell | Tax Withholding | 2,261 | $3K | 1/25/2025 |
| DeYoung Casi | ▼ Sell | Tax Withholding | 2,297 | $3K | 1/25/2025 |
| Pandite Arundathy N. | ▼ Sell | Tax Withholding | 3,211 | $4K | 1/25/2025 |
| Pandite Arundathy N. | ▼ Sell | Tax Withholding | 6,884 | $8K | 1/10/2025 |
| DeYoung Casi | ▼ Sell | Tax Withholding | 5,727 | $7K | 1/10/2025 |
| Shukla Abhinav A. | ▼ Sell | Tax Withholding | 4,830 | $6K | 1/10/2025 |
| Redmile Group, LLC | ▼ Sell | Other | 1,026,888 | $1.3M | 12/4/2024 |
| Redmile Group, LLC | ▼ Sell | Open Market | 133,371 | $167K | 12/4/2024 |
| Redmile Group, LLC | ▲ Buy | Open Market | 133,371 | $167K | 12/4/2024 |
| Redmile Group, LLC | ▼ Sell | Other | 1,026,888 | $1.3M | 12/4/2024 |
| Schreiber Taylor | ▲ Buy | Open Market | 36,500 | $44K | 10/7/2024 |
| Tyler Brous | ▲ Buy | Open Market | 3,000 | $12K | 6/28/2024 |
| Tyler Brous | ▲ Buy | Open Market | 5,416 | $21K | 6/27/2024 |
| Schreiber Taylor | ▲ Buy | Open Market | 14,400 | $50K | 6/26/2024 |
| Schreiber Taylor | ▲ Buy | Option Exercise | 3,050 | $11K | 6/4/2024 |
| Stout Stephen | ▼ Sell | Tax Withholding | 967 | $10K | 5/10/2024 |
| Redmile Group, LLC | ▼ Sell | Other | 4,425 | $0 | 3/28/2024 |
| Stout Stephen | ▼ Sell | Open Market | 4,650 | $49K | 3/6/2024 |
| Stout Stephen | ▲ Buy | Option Exercise | 4,650 | $16K | 3/6/2024 |
| Stout Stephen | ▲ Buy | Option Exercise | 6,459 | $23K | 3/6/2024 |
| Stout Stephen | ▼ Sell | Open Market | 6,459 | $68K | 3/6/2024 |
| Stout Stephen | ▼ Sell | Open Market | 4,895 | $52K | 3/6/2024 |
| Pandite Arundathy N. | ▼ Sell | Tax Withholding | 2,920 | $29K | 1/30/2024 |
| Stout Stephen | ▼ Sell | Tax Withholding | 593 | $6K | 1/30/2024 |
| Shukla Abhinav A. | ▼ Sell | Tax Withholding | 2,290 | $23K | 1/30/2024 |
| DeYoung Casi | ▼ Sell | Tax Withholding | 2,008 | $20K | 1/30/2024 |
| DeYoung Casi | ▼ Sell | Tax Withholding | 1,583 | $16K | 1/10/2024 |
| Shukla Abhinav A. | ▲ Buy | Grant | 33,425 | $0 | 1/10/2024 |
| Stout Stephen | ▲ Buy | Grant | 49,050 | $0 | 1/10/2024 |
| DeYoung Casi | ▲ Buy | Grant | 46,200 | $0 | 1/10/2024 |
| Neill Andrew R | ▲ Buy | Grant | 56,500 | $0 | 1/10/2024 |
| Neill Andrew R | ▼ Sell | Tax Withholding | 2,470 | $25K | 1/10/2024 |
| Neill Andrew R | ▼ Sell | Open Market | 25,000 | $250K | 1/10/2024 |
| Pandite Arundathy N. | ▲ Buy | Grant | 46,475 | $0 | 1/10/2024 |
| Pandite Arundathy N. | ▼ Sell | Tax Withholding | 2,987 | $30K | 1/10/2024 |
| Stout Stephen | ▲ Buy | Grant | 15,900 | $0 | 5/10/2023 |
| Neill Andrew R | ▲ Buy | Grant | 34,925 | $0 | 1/25/2023 |
| Thomson Erin Ator | ▲ Buy | Grant | 24,125 | $0 | 1/25/2023 |
| Shukla Abhinav A. | ▲ Buy | Grant | 26,100 | $0 | 1/25/2023 |
| Pandite Arundathy N. | ▲ Buy | Grant | 37,875 | $0 | 1/25/2023 |
| DeYoung Casi | ▲ Buy | Grant | 27,100 | $0 | 1/25/2023 |
| DeYoung Casi | ▼ Sell | Tax Withholding | 1,583 | $5K | 1/10/2023 |
| Pandite Arundathy N. | ▼ Sell | Tax Withholding | 2,987 | $9K | 1/10/2023 |
| Shukla Abhinav A. | ▼ Sell | Tax Withholding | 1,933 | $6K | 1/10/2023 |
| George Golumbeski | ▲ Buy | Open Market | 28,330 | $103K | 4/26/2022 |
| George Golumbeski | ▲ Buy | Open Market | 234 | $859 | 4/22/2022 |
| George Golumbeski | ▲ Buy | Open Market | 26,049 | $96K | 4/21/2022 |
| Schreiber Taylor | ▲ Buy | Option Exercise | 3,926 | $18K | 1/28/2022 |
| Tyler Brous | ▲ Buy | Open Market | 3,000 | $21K | 1/19/2022 |
| Tyler Brous | ▲ Buy | Open Market | 2,500 | $18K | 1/18/2022 |
| Tyler Brous | ▲ Buy | Open Market | 2,500 | $18K | 1/14/2022 |
| Thomson Erin Ator | ▲ Buy | Option Exercise | 10,000 | $30K | 1/12/2022 |
| DeYoung Casi | ▲ Buy | Grant | 21,363 | $0 | 1/10/2022 |
| Pandite Arundathy N. | ▲ Buy | Grant | 34,738 | $0 | 1/10/2022 |
| Neill Andrew R | ▲ Buy | Grant | 33,325 | $0 | 1/10/2022 |
| Thomson Erin Ator | ▲ Buy | Grant | 22,825 | $0 | 1/10/2022 |
| Neill Andrew R | ▲ Buy | Option Exercise | 20,000 | $59K | 11/11/2021 |
| Schreiber Taylor | ▲ Buy | Option Exercise | 3,926 | $18K | 11/10/2021 |
| Thomson Erin Ator | ▼ Sell | Open Market | 33,000 | $644K | 10/19/2021 |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 16, 2026
UBS initiates coverage on Shattuck Labs with $17 price target
UBS has started covering Shattuck Labs, assigning a price target of $17. This new analyst view comes as the company prepares to present research at UEG Week 2026. The stock is currently trading near its 52-week low, making this fresh institutional attention a notable development for the company.
UBS initiates coverage on Shattuck Labs with $17 price target. UBS has started covering Shattuck Labs, assigning a price target of $17. This new analyst view comes as the company prepares to present research at UEG Week 2026. The stock is currently trading near its 52-week low, making this fresh institutional attention a notable development for the company.